En la esclerosis sistémica, el esófago se afecta en un 90%, seguido de los tramos anorrectal (%), gástrico ( 70%), colon (%) e intestino delgado. La esclerodermia es un relativamente infrecuente enfermedad reumática autoinmunitaria que afecta la piel y otros órganos del cuerpo. La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo, que se caracteriza por un depósito excesivo de tejido colágeno y otros.

Author: Shaktigore Samugal
Country: Argentina
Language: English (Spanish)
Genre: Relationship
Published (Last): 20 October 2004
Pages: 266
PDF File Size: 6.97 Mb
ePub File Size: 3.59 Mb
ISBN: 221-9-98726-499-6
Downloads: 15969
Price: Free* [*Free Regsitration Required]
Uploader: Zulushakar

Am J Med, 61pp. Succesful treatment of systemic sclerosis digital ulcers and pulmonary arterial hipertension with endothelin receptor antagonist bosentan.

You can change the settings or obtain more information by clicking here. Curr Med Res Opin, 23pp.

Ventricular late potentials in systemic sclerosis: J Hand Surgery, 27App. Pediatrics, 83pp. Ann Intern Med,pp. J Rheumatol, 23pp. sistemida

Am J Med, 71pp. Effect of cold stress on coronary sinus blood flow in patients with scleroderma.

Myocardial lesions of progressive systemic sclerosis. Biomed Pharmacother, 50pp. Clin Rheumatol, 25pp. Oral iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis: Minerva Cardioangiol, 47pp. A double-blind controlled trial. At admission, hemoglobin level was 8. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated sisetmica via CD Br Heart J, 23pp.


J Rheumatol, 28pp. J Rheumatol, 25pp. Rheumatology, 39pp. Ann Rheum Esclerksis, 44pp. Mymensingh Med J, 14pp. Botulinum toxin in the treatment of Raynaud’s phenomenon: Clin Exp Rheumatol, 16pp. Giusti De Marle, A.

Vascular involvement in systemic sclerosis [review]. Efficacy evaluation of prostaglandin E1 against placebo in patients with progressive systemic sclerosis and significant Raynaud’s phenomenon. Clin Exp Rheumatol, 21pp.

Afección cardíaca en la esclerosis sistémica | Reumatología Clínica

The cardiac conduction system in progressive systemic sclerosis: Postgrad Med Sistemoca ; Losartan therapy for Raynaud’s phenomenon and scleroderma. Semin Arthritis Rheum, 30pp. Nailfold video-capillaroscopy in systemic-sclerosis. J Rheumatol, 19pp. Management of Raynaud’s phenomenon and digital ischemic lesions in scleroderma. Subjective and objective assessment sistwmica enalapril in primary Raynaud’s phenomenon.

Diastolic abnormalities in systemic sclerosis: A study of the frequency of pericardial and pleural effusions in scleroderma. Clin Rheumatol, 21pp.

There is an increased prevalence of arrhytmias, mainly premature atrial and ventricular contractions, as well as conduction system disease. Diag Imaging Clin Med, 55pp. Prevention by treatment with bosentan, an oral endothelin receptor antagonist.


J Rheumatol, 32pp. Europace, 6pp.

Clin Exp Rheumatol, 1esclefosis. Since melena is not always possible to detect in these patients, test for fecal occult blood would be advisable and, if positive, colonoscopy should be performed, specially when anemia is detected associated with this disease.

These lesions are extremely painful, heal slowly and lead to substantial functional disability.

There was a problem providing the content you requested

Reumatismo, 59pp. Ann Rheum Dis, 56pp. Intravenous iloprost treatment of Raynaud’s phenomenon and ischemic ulcers secondary to systemic sclerosis. J Nucl Med, 42pp. Case report A 50 year old male, with no relevant family history, who was diagnosed of subclinical hypothyroidism and early scleroderma has been follow-up by Rheumatology and Dermatology.